Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer

被引:2
|
作者
Herold, Alexander [1 ]
Wassipaul, Christian [1 ]
Weber, Michael [1 ]
Lindenlaub, Florian [1 ]
Rasul, Sazan [1 ]
Stift, Anton [2 ]
Stift, Judith [3 ,4 ]
Mayerhoefer, Marius E. [1 ,5 ]
Hacker, Marcus [1 ]
Ba-Ssalamah, Ahmed [1 ]
Haug, Alexander R. [1 ,6 ]
Tamandl, Dietmar [1 ]
机构
[1] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Gen Surg, Vienna, Austria
[3] Med Univ Vienna, Dept Pathol, Vienna, Austria
[4] INNPATH GmbH, Tirolkliniken, Innsbruck, Austria
[5] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA
[6] Med Univ Vienna, Christian Doppler Lab Appl Metabol, Vienna, Austria
关键词
PET; MRI; MR; Rectal cancer; Staging; DIFFUSION-WEIGHTED MRI; COLORECTAL-CANCER; PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; CHEMOTHERAPY; RADIOTHERAPY; SOCIETY;
D O I
10.1007/s00259-022-05936-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The purpose of this study was to determine whether multiparametric positron emission tomography/magnetic resonance imaging (mpPET/MRI) can improve locoregional staging of rectal cancer (RC) and to assess its prognostic value after resection. Methods: In this retrospective study, 46 patients with primary RC, who underwent multiparametric 18F-fluorodeoxyglucose (FDG) PET/MRI, followed by surgical resection without chemoradiotherapy, were included. Two readers reviewed T- and N- stage, mesorectal involvement, sphincter infiltration, tumor length, and distance from anal verge. In addition, diffusion-weighted imaging (DWI) and PET parameters were extracted from the multiparametric protocol and were compared to radiological staging as well as to the histopathological reference standard. Clinical and imaging follow-up was systematically assessed for tumor recurrence and death. Results: Locally advanced rectal cancers (LARC) exhibited significantly higher metabolic tumor volume (MTV, AUC 0.74 [95% CI 0.59-0.89], p = 0.004) and total lesion glycolysis (TLG, AUC 0.70 [95% CI 0.53-0.87], p = 0.022) compared to early tumors. T-stage was associated with MTV (AUC 0.70 [95% CI 0.54-0.85], p = 0.021), while N-stage was better assessed using anatomical MRI sequences (AUC 0.72 [95% CI 0.539-0.894], p = 0.032). In the multivariate regression analysis, depending on the model, both anatomical MRI sequences and MTV/TLG were capable of detecting LARC. Combining anatomical MRI stage and MTV/TLG led to a superior diagnostic performance for detecting LARC (AUC 0.81, [95% CI 0.68-0.94], p < 0.001). In the survival analysis, MTV was independently associated with overall survival (HR 1.05 [95% CI 1.01-1.10], p = 0.044). Conclusion: Multiparametric PET-MRI can improve identification of locally advanced tumors and, hence, help in treatment stratification. It provides additional information on RC tumor biology and may have prognostic value.
引用
收藏
页码:205 / 217
页数:13
相关论文
共 50 条
  • [41] The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer
    Murcia Durendez, M. J.
    Frutos Esteban, L.
    Lujan, J.
    Frutos, M. D.
    Valero, G.
    Navarro Fernandez, J. L.
    Salem, L. Mohamed
    Ruiz Merino, G.
    Claver Valderas, M. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) : 91 - 97
  • [42] Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery
    Hotta, Masatoshi
    Minamimoto, Ryogo
    Gohda, Yoshimasa
    Miwa, Kenta
    Otani, Kensuke
    Kiyomatsu, Tomomichi
    Yano, Hideaki
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (07) : 843 - 852
  • [43] Performance of 18F-FDG PET/MRI and its parameters in staging and neoadjuvant therapy response evaluation in bladder cancer
    Li, Tianhang
    You, Qinqin
    Zhang, Shiwei
    Li, Rushuai
    Xie, Shangxun
    Li, Danyan
    Ai, Shuyue
    Yang, Rong
    Guo, Hongqian
    ISCIENCE, 2024, 27 (05)
  • [44] A Simultaneous Multiparametric 18F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer
    Romeo, Valeria
    Kapetas, Panagiotis
    Clauser, Paola
    Baltzer, Pascal A. T.
    Rasul, Sazan
    Gibbs, Peter
    Hacker, Marcus
    Woitek, Ramona
    Pinker, Katja
    Helbich, Thomas H.
    CANCERS, 2022, 14 (16)
  • [45] AI-enhanced simultaneous multiparametric 18F-FDG PET/MRI for accurate breast cancer diagnosis
    Romeo, V.
    Clauser, P.
    Rasul, S.
    Kapetas, P.
    Gibbs, P.
    Baltzer, P. A. T.
    Hacker, M.
    Woitek, R.
    Helbich, T. H.
    Pinker, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (02) : 596 - 608
  • [46] The role of MRI and 18F-FDG PET/CT with respect to evaluation of pathological response in the rectal cancer patients after neoadjuvant chemoradiotherapy
    Avci, Gulhan Guler
    Aral, Ipek Pinar
    INDIAN JOURNAL OF CANCER, 2023, 60 (01) : 52 - 58
  • [47] Comparison of 18F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix
    Sarabhai, Theresia
    Schaarschmidt, Benedikt M.
    Wetter, Axel
    Kirchner, Julian
    Aktas, Bahriye
    Forsting, Michael
    Ruhlmann, Verena
    Herrmann, Ken
    Umutlu, Lale
    Grueneisen, Johannes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (01) : 67 - 76
  • [48] 18F-FDG PET/CT and MRI of Necrobiotic Xanthogranuloma
    Ba Duong Nguyen
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (01) : E101 - E103
  • [49] Use of 18F-FDG PET/MRI as an Initial Staging Procedure for Nasopharyngeal Carcinoma
    Cao, Caineng
    Fang, Yuting
    Yu, Bocheng
    Xu, Yuanfan
    Qiang, Mengyun
    Tao, Changjuan
    Huang, Shuang
    Chen, Xiaozhong
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024, 59 (03) : 922 - 928
  • [50] Value of 18F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With 18F-FDG PET/CT, MRI, and Contrast-Enhanced CT
    Wang, Fei
    Guo, Rui
    Zhang, Yan
    Yu, Boqi
    Meng, Xiangxi
    Kong, Hanjing
    Yang, Yang
    Yang, Zhi
    Li, Nan
    FRONTIERS IN ONCOLOGY, 2022, 12